Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06182332 · ClinicalTrials.gov registry record · NA

An Artificial Intelligence Algorithm for Identifying Gynecologic Cancer Patients in Need of Outpatient Palliative Care

A NA study, sponsored by Mayo Clinic.

Completed
Registry status
NA
Development phase
221
Enrollment target

NCT06182332: Completed NA study, sponsored by Mayo Clinic.

NCT06182332 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 221 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT06182332, a NA study, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
NA
Development phase
221 participants
Enrollment target

Study Summary

This clinical trial tests an artificial intelligence (AI) algorithm for its ability to identify patients who may benefit from a palliative care consult for gynecologic cancer that has spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced). A significant delay in referral to palliative care often occurs among patients with cancer. This delay can lead to poorer symptom management, decreased quality of life, and care that does not align with patient goals or values. AI algorithms are computer programs that use step-by-step procedures to solve a problem. In this trial, an AI algorithm is applied to patients' medical records in order to identify patients with a high burden of disease. Information gathered from this study may help researchers learn whether this AI algorithm is useful for identifying patients who could benefit from outpatient palliative care consultation.

Primary Outcome

Will be measured as time to the electronic record of consult by the palliative care team in the outpatient setting.

Interventions

  • OTHER Electronic Health Record Review
  • OTHER Internet-Based Intervention

Trial Details

FieldValue
Enrollment Target 221 participants
Start Date 2023-12-11
Est. Completion 2024-07-26
Phase NA
Mayo Clinic

2,844 total trials

What the finished NCT06182332 record still lists

NCT06182332 is an interventional study that assigns participants to a tested intervention. The registered 221 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower).

The record links to 0 conditions, and to 2 interventions - of which Electronic Health Record Review is the first listed.

NCT06182332 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT06182332 about?

NCT06182332 is a clinical study titled "An Artificial Intelligence Algorithm for Identifying Gynecologic Cancer Patients in Need of Outpatient Palliative Care". This clinical trial tests an artificial intelligence (AI) algorithm for its ability to identify patients who may benefit from a palliative care consult for gynecologic cancer that has spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced). A signifi...

What is the current status of trial NCT06182332?

This trial is currently completed. It is a NA study. The enrollment target is 221 participants. The study started on 2023-12-11. Estimated completion is 2024-07-26.

What interventions are being tested in trial NCT06182332?

The interventions under investigation include: Electronic Health Record Review (OTHER), Internet-Based Intervention (OTHER).

Who is sponsoring clinical trial NCT06182332?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT06182332's enrollment target sits among peer trials

221 481st of 2000 higher than 1,520 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03170440 · 221 participants · NA

    Non-invasive Nerve Stimulation for PTSD and Sleep

  • NCT04939610 · 222 participants · Phase 1

    A Study of 177Lu-FAP-2286 in Advanced Solid Tumors

  • NCT05424783 · 222 participants

    MRI And GPS Informing Choices for Prostate Cancer Treatment (MAGIC)

  • NCT05568264 · 222 participants · NA

    Effects of a Physical Therapy Intervention on Motor Delay in Infants Admitted to a Neonatal Intensive Care Unit

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06182332, the US trial registry maintained by the National Library of Medicine. NCT06182332 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.